The International Journal of Cancer Impact Factor IF measures the average number of citations received in a particular year 2020 by papers published in the International Journal of Cancer during the two preceding years 2018-2019. There are over manifold types of cancer and each is classified by the type of cell that is initially affected.
They cannot be calculated until all of the 2020 publications have been processed by the indexing agency.
Journal of cancer science impact factor. The 2019-2020 Journal Impact IF of Cancer Science is 4966 Cancer Science Key Factor Analysis The 2018-2019 Journal Impact IF of Cancer Science is 4751 Cancer Science Key Factor Analysis The 2017-2018 Journal Impact IF of Cancer Science is 4555 Cancer Science Key Factor Analysis. 11 Zeilen Cancer Science Impact Factor IF number of article detailed information and journal. The Journal of Cancer Science and Therapy Impact Factor IF measures the average number of citations received in a particular year 2020 by papers published in the Journal of Cancer Science and Therapy during the two preceding years 2018-2019.
Note that 2020 Impact Factor are reported in 2021. They cannot be calculated until all of the 2020 publications have been processed by the indexing. 0178 2012 0158 2013 0255 2014 0326 2015 0261 2016 0202 2017 The SJR is a size-independent prestige indicator that ranks journals by their average prestige per article.
It is based on the idea that all citations are not created equal. SJR is a measure of scientific influence of journals that accounts for both the number of. ARC Journal of Cancer Science is an open access peer reviewed multidisciplinary journal which covers all parts of tumor exploration including essential preclinical clinical translational sub-atomic epidemiological avoidance treatment and recovery.
It lays an in number establishing discussion for Oncologists Physician General Surgeons Gynaecologists Dermatologists. 11 Index Copernicus Value. 10352 Research Gate Journal Impact- 045 Journal of Cancer Sciences and Therapy is a peer reviewed journal serving the International Scientific Community.
This journal offers an open access platform to the authors to publish their research outcome and thus help in promoting Cancer and Oncology research. This review depicts this new trend of cancer therapy in which the common feature that is expected to play a major role in prolonging the survival of cancer patients is an induction of specific antitumor immunity in the course of tumor specific viral replication. It is likely that cancer patients will be able to choose oncolytic virus therapy freely as a treatment option in the very near future.
Journal of Cancer Science and Clinical Therapeutics publishes high-impact peer-reviewed articles significant advances in translational and clinical cancer research. The Journal publishes original articles review articles editorials letters to the editor short communication case reports describing original research in the fields of basic new techniques in cancer research and therapy. European Journal of Cancer.
Journal of Hematology and Oncology. Biochimica et Biophysica Acta - Reviews on Cancer. LINC01272miR-876ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition Zhenqiang Sun Qin Dang Zaoqu Liu Bo Shao Chen Chen Yuying Guo Zhuang Chen Quanbo Zhou Shengyun Hu Jinbo Liu Weitang Yuan J.
Journal of Experimental and Clinical Cancer Research Impact Factor 565 IF number of citations detailed analysis and journal factor. The International Journal of Cancer Impact Factor IF measures the average number of citations received in a particular year 2020 by papers published in the International Journal of Cancer during the two preceding years 2018-2019. Note that 2020 Impact Factor are reported in 2021.
They cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals which are indexed from their first published issue will receive an impact factor. The Journal of Cancer Science and Research is an open access Journal that features high quality articles in cancer biology and research.
The journal deals with research pertaining to different types of cancer such as. Prostate cancer bladder cancer bone cancer blood cancer brain cancer cervical cancer ovarian cancer breast cancer renal cancer endocrine cancer HPV-associated cancer head and neck cancer oral cancer colorectal cancer gastric cancer pancreatic cancer skin cancer. Journal of Cancer Science and Clinical Oncology JCSCO is an Open Access publication Journal and its objective is to publish most complete and reliable supply of data on the discoveries and modern developments within the mode of authentic articles review articles case reports short communications etc.
In every area of the sector and creating them freely accessible through on-line with no restrictions. He is author of 216 original articles published on indexed journals and he serves as a reviewer of several scientific journals. Starting from his first doctoral degree in Biological Sciences 1982 he worked on functional characteristics of leukocyte subsets.
After his Post-Doctoral Fellow training at the Ludwig Cancer Institute in Lausanne Switzerland 1985-1987 he has been appointed as Assistant Member. Cancer is a class of diseases characterized by out-of-control cell growth. There are over manifold types of cancer and each is classified by the type of cell that is initially affected.
Cancer science aims to represent research that has a significant clinical impact on oncologists that may alter the disease concept of. Cancer Science Research ISSN 2639-8478 is an online peer-reviewed journal that provides the oncologist with up-to-date information on all aspects of cancer diagnosis treatment and prevention. The scope of JCR covers basic translational and clinical research in a vast range of cancer.
Ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs. The ISSN of the journal is 15424863 and 00079235.
According to the Scimago Journal Ranking this journal has an SJR value and H-index of 88192 and 156 respectively. Scimago Journal Rank indicator SJR is a measure of journal impact influence or prestige. Similarly CA A Cancer Journal for Clinicians has an Impact Factor 292278.